EP400 and neuroblastoma: We reasoned those systematic comparisons of the levels of statistical significance of enrichment of expression signatures comprising genes affected by BG-P400-TAT treatment in human neuroblastoma cells would help to identify gene expression pathways and signaling networks representing candidate molecular targets of BG-P400-TAT anti-cancer activities.